SCHOTT Pharma
Marcel Lauer is a Senior Production IT Engineer at SCHOTT Pharma, specializing in GMP coordination of OT Applications since September 2022. Prior to this role, Marcel completed certification in project management at Reuter management academy and has extensive experience at OPEL Automobile GmbH, where responsibilities included project lead for IT migration, vehicle industrialization, and European Lead for EndOfLine programming and testing, successfully launching EOL software across seven European assembly plants. Marcel began their career as a Project Engineer at DSA Daten- und Systemtechnik GmbH and holds a Master of Science in PC Interfacing and Software Applications, along with a Bachelor of Science in Applied Physics from the University of Lancashire.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social